Hutch biotech spinoff snags $105 million – The Seattle Times

Hutch biotech spinoff snags $105 million
The Seattle Times
Adaptive Biotechnologies, a Seattle startup that focuses on scouring the genetic makeup of the immune system to help fight cancer and other diseases, said Monday it has raised an eye-popping $105 million in funding to boost its research and commercial …

and more

…read more

Source: Seattle News From Google

    

Leave a Comment